Molecular characterization of feline COX-2 and expression in feline mammary carcinomas

Veterinary Pathology

Volumn 46, Issue 3, 2009, Pages 423-429

  Sayasith, K ^a   Sirois, J ^a   Dore M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cancer; Carcinomas; Cats; Cyclooxygenase 2; Immunohistochemistry; Mammary

Indexed keywords

CANIS FAMILIARIS; FELIDAE; MAMMALIA;

CYCLOOXYGENASE 2;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CAT; CAT DISEASE; CHEMISTRY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CAT DISEASES; CATS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; MOLECULAR SEQUENCE DATA;

EID: 67649989252     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0161-D-FL     Document Type: Article

References (29)

1. Beam SL, Rassnick KM, Moore AS, McDonough SP: An immunohistochemical study of cyclooxygen-ase-2 expression in various feline neoplasms. Vet Pathol 40:496-500, 2003
2. Bertagnolli MM: Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back. Lancet Oncol 8:439-443, 2007
3. Boerboom D, Sirois J: Molecular characterization of equine prostaglandin G/H synthase-2 and regulation of its messenger ribonucleic acid in preovulatory follicles. Endocrinology 139:1662-1670, 1998
4. Boutemmine D, Bouchard N, Boerboom D, Jones HE, Goff AK, Dore M, Sirois J: Molecular characterization of canine prostaglandin G/H syn-thase-2 and regulation in prostatic adenocarcinoma cells in vitro. Endocrinology 143:1134-1143, 2002
5. Cha YI, DuBois RN: NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239-252, 2007
6. DiBernardi L, Dore M, Davis JA, Owens JG, Mohammed SI, Guptill CF, Knapp DW: Study of feline oral squamous cell carcinoma : potential target for cyclooxygenase inhibitor treatment. Prostaglan-dins Leukot Essent Fatty Acids 76:245-250, 2007
7. Dore M, Lanthier I, Sirois J: Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 40:207-212, 2003
8. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A: Breast cancer and nonste-roidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63:6096-6101, 2003
9. Hayes A, Scase T, Miller J, Murphy S, Sparkes A, Adams V: COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol 135:93-99, 2006
10. Heller DA, Clifford CA, Goldschmidt MH, Holt DE, Shofer FS, Smith A, Sorenmo KU: Cyclooxy- genase-2 expression is associated with histologic tumor type in canine mammary carcinoma. Vet Pathol 42:776-780, 2005
11. Heller DA, Fan TM, De Lorimier LP, Charney SC, Barger AM, Tannehill-Gregg SH, Rosol TJ, Wallig MA: In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells. J Vet Intern Med 21:1048-1055, 2007
12. Khan KN, Knapp DW, Denicola DB, Harris RK: Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res 61:478-481, 2000
13. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor-promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxy-genase homologue. J Biol Chem 266:12866-12872, 1991
14. Liu J, Antaya M, Goff AK, Boerboom D, Silversides DW, Lussier JG, Sirois J: Molecular characterization of bovine prostaglandin G/H synthase-2 and regulation in uterine stromal cells. Biol Reprod 64:983-991, 2001
15. Mazhar D, Waxman J: COX inhibitors and breast cancer. Br J Cancer 94:346-350, 2006
16. McEntee MF, Cates JM, Neilsen N: Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 39:428-436, 2002
17. Millanta F, Citi S, Della Santa D, Porciani M, Poli A: COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopath-ological features and prognostic molecular markers. Breast Cancer Res Treat 98:115-120, 2006
18. Mohammed SI, Khan KN, Sellers RS, Hayek MG, DeNicola DB, Wu L, Bonney PL, Knapp DW: Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 70:479-483, 2004
19. Novosad CA, Bergman PJ, O'Brien MG, McKnight JA, Charney SC, Selting KA, Graham JC, Correa SS, Rosenberg MP, Gieger TL: Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 42:110-120, 2006
20. Pestili de Almeida EM, Piché C, Sirois J, Doré M: Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 49:867-875, 2001
21. Pontius JU, Mullikin JC, Smith DR, Agencourt Sequencing Team, Lindblad-Toh K, Gnerre S, Clamp M, Chang J, Stephens R, Neelam B, Volfovsky N, Schäffer AA, Agarwala R, Narfström K, Murphy WJ, Giger U, Roca AL, Antunes A, Menotti-Raymond M, Yuhki N, Pecon-Slattery J, Johnson WE, Bourque G, Tesler G, NISC Comparative Sequencing Program, O'Brien SJ: Initial sequence and comparative analysis of the cat genome. Genome Research 17:1675-1689, 2007
22. Queiroga FL, Alves A, Pires I, Lopes C: Expression of Cox-1 and Cox-2 in canine mammary tumours. J Comp Path 136:177-185, 2007
23. Simmons DL, Botting RM, Hla T: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological Reviews 56:387-437, 2004
24. Singh Ranger G, Salhab M, Mokbel K: The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res Treat 109:189-198, 2008
25. Sinicrope FA: Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog 45:447-454, 2006
26. Williams CS, DuBois RN: Prostaglandin endoper-oxide synthase: why two isoforms? Am J Physiol 270:G393-400, 1996
27. Williams CS, Mann M, DuBois RN: The role of cyclooxygenases in inflammation, cancer and development. Oncogene 18:7908-7916, 1999
28. Zha S, Yegnasubramanian V, Nelson W, Isaacs W, De Marzo A: Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215:1-20, 2004
29. 3Zhang V, O'Sullivan M, Hussain H, Roswit WT, Holtz-man MJ: Molecular cloning, functional expression and selective regulation of ovine prostaglandin H synthase-2. Biochem Biophys Res Commun 227:499-506, 1996